Repligen Corporation (RGEN)
Cash ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 757,355 | 751,323 | 523,458 | 603,814 | 717,292 |
Short-term investments | US$ in thousands | 26,609 | 0 | 100,299 | 0 | — |
Total current liabilities | US$ in thousands | 126,787 | 158,162 | 404,196 | 375,262 | 318,956 |
Cash ratio | 6.18 | 4.75 | 1.54 | 1.61 | 2.25 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($757,355K
+ $26,609K)
÷ $126,787K
= 6.18
The cash ratio of Repligen Corporation has shown fluctuating trends over the years. It stood at 2.25 on December 31, 2020, indicating that the company had $2.25 of cash and cash equivalents for every dollar of current liabilities. Subsequently, the ratio decreased to 1.61 on December 31, 2021, and further dropped to 1.54 on December 31, 2022.
However, the cash ratio saw a significant improvement in the following years, reaching 4.75 on December 31, 2023, and further increasing to 6.18 on December 31, 2024. These higher ratios suggest that Repligen Corporation had an increased ability to cover its short-term liabilities with its available cash resources in the latter years, reflecting improved liquidity position and potentially reduced financial risk.
Peer comparison
Dec 31, 2024